• Activity Title

    Start Activity


    The Ketogenic Diet as a Treatment for Type II Diabetes

     

  • Statement of Need/Program Overview

    The purpose of this CME activity is to educate practicing physicians and other healthcare professionals about the clinical evidence supporting nutritional ketosis as a treatment for Type 2 diabetes. This evidence demonstrates that a ketogenic diet can effectively improve insulin resistance, glycemic control, and various metabolic parameters. By presenting the current evidence, we aim to help clinicians understand when and how to implement this dietary intervention safely and effectively.

  • Target Audience

    This activity is designed for primary care and psychiatric physicians, cardiologists, endocrinologists, nurse practitioners and physician assistants as well as licensed mental health therapists and dieticians. All levels of experience are welcome.

  • Educational Objectives

    After completing this activity, the participant should be better able to:

    1. Explain the relationship between insulin resistance and Type 2 diabetes development.
    2.  Describe how the ketogenic diet improves insulin sensitivity.
    3.  Identify the clinical markers and diagnostic criteria for insulin resistance and Type 2 diabetes.
    4.  Recognize the relationship between insulin resistance and cardiovascular risk.
    5.  Recognize the clinical considerations and potential risks when implementing a ketogenic diet in diabetic patients.
    6.  Recognize the important clinical variables and potential risks when implementing a ketogenic diet in diabetic patients.
    7. Describe appropriate diabetes medication adjustments needed when initiating a ketogenic diet.
    8. Incorporate acquired knowledge on the latest findings on Ketogenic Diet as a Treatment for Type II Diabetes into current practice to better address the needs of their patients, to educate patients, and to optimize patient outcomes.

  • Faculty

    Mariela Glandt, MD
    Endocrinologist
    CEO, OwnaHealth

    Bret Scher, MD
    Cardiologist 
    Medical Director, Baszucki Group and Metabolic Mind

  • Program Agenda

    Educational Presentation (73 minutes)
    Post Test and Evaluation (10 minutes)
    Total Activity (83 minutes)

  • EACCME Term Offering

    November 28, 2025 to November 28, 2027  

    Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM . Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications.

    Information regarding the conversion of EACCME® credits
    Credit will be converted based on one (1) hour of participation equalling one credit for all activities. Physicians wishing to convert EACCME® credits to AMA PRA Category 1 Credit™ will be required to access the AMA website at https://edhub.ama-assn.org/pages/applications to obtain the necessary paperwork and instructions. Physicians and other health care professionals will be required to pay a processing fee to the AMA.

    For other countries, please contact the relevant national/regional accreditation authority.

  • European Accreditation Council for Continuing Medical Education (EACCME)

    EACCME Accreditation Statement

    The "The Ketogenic Diet as a Treatment for Type II Diabetes", made available and organized by Dane Garvin Ltd., is accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) to provide the following CME activity for medical specialists. 

    Only those e-learning materials that are displayed on the UEMS-EACCME® website have formally been accredited.

  • American Academy of Family Physicians (AAFP) Accreditation

    AAFP Accreditation Statement
    The AAFP has reviewed The Ketogenic Diet as a Treatment for Type II Diabetes and deemed it acceptable for up to 1.0 Enduring Materials, Self-Study AAFP Prescribed credit(s). Term of Approval is from 11/10/2025 to 11/10/2027. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

     

  • Other Allied Healthcare Professional

    Participation Statement
    Dane Garvin Ltd. has awarded 1.0 Participation Credit(s) for qualified attendees in the enduring activity The Ketogenic Diet as a Treatment for Type II Diabetes.

  •  

  • Educational Grant

    This activity is supported by an educational grant from Metabolic Mind which is a non-profit organization.

  • Copyright

    Copyright© Dane Garvin Ltd. All Rights Reserved. Permission for use granted to accreditation providers.

  • Web interface provided by Dane Garvin Ltd.

     

Contact Us